Left ventricular hypertrophy: Diagnostic pitfalls

Swiss Medical Weekly

Volumn 134, Issue 19-20, 2004, Pages 289-292

  Bonvini, Robert Francis ^a   Camenzind, Edoardo ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cardiac amyloidosis; Endo myocardial biopsy; Hypertrophic cardiomyopathy

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; ATRIOVENTRICULAR BLOCK; BONE MARROW BIOPSY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAM; FEMALE; GAMMOPATHY; HEART AMYLOIDOSIS; HEART CATHETERIZATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MITRAL VALVE REGURGITATION; MULTIPLE ORGAN FAILURE; PERICARDIAL EFFUSION; PROGNOSIS; PROTEINURIA; TREATMENT PLANNING;

EID: 3042626094     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Eriksson P, Backman C, Eriksson C, et al. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography. Acta Med Scand. 1987; 221(1): 39-46.
2. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Eng J Med 1997;337:898-909
3. Gertz MA, Kyle RA, Primary systemic amyloidosis - a diagnostic primer. Mayo Clin Proc. 1989 Dec;64(12):1505-19.
4. Weston LT, Raybuck BD, Robinowitz M, et al. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy. Cathet Cardiovasc Diagn. 1986;12(3):176-81.
5. Presti CF, Waller BF, Armstrong WF. Cardiac amyloidosis mimicking the echocardiographic appearance of obstructive hypertrophic myopathy. Chest. 1988 Apr;93(4):881-3.
6. Dubrey SW, Cha K, Anderson J, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM. 1998 Feb;91(2):141-57.
7. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995 Jan;32 (1):45-59.
8. Comenzo RL, Vosburgh E, Falk RH, et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood. 1998 May 15;91(10):3662-70.
9. Pellikka PA.Holmes DR Jr., Edwards WD, et al. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Arch Intern Med. 1988 Mar; 148(3):662-6.
10. Arbustini E, Merlini G, Gavazzi A, et al. Cardiac immunocytederived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. Am Heart J. 1995 Sep;130(3 Pt 1):528-36.
11. Rahman JE, Helou EF, Gelzer-Bell R, et al., Noninvasive diagnosis of biopsy-proven cardiac amyloidosis, J Am Coll Cardiol. 2004 Feb;43(3):410-415
12. Falk RH, Plehn JF, Deering T, et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol. 1987 Feb 15;59(5):418-22.
13. Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol. 1992 Jan;19(1):43-7.
14. Buchanan WP, Schreiter SW, Kahl FR, et al. Double cardiomyopathy: coexistent cardiac amyloidosis and hypertrophic obstructive cardiomyopathy. J Am Soc Echocardiogr. 1993 Jan-Feb;6(1):87-90.
15. Kohno I, Komori S, Yamamoto K, et al. Hypertrophic cardiomyopathy complicated with cardiac amyloidosis. Intern Med. 2000 Aug;39(8):637-40.
16. Kotha AR, Weiss MB. Cardiac amyloidosis: a case report and therapeutic implications. Heart Dis. 2002 Mar-Apr;4(2):86-90.
17. Moreau P. Leblond V, Bourquelot P, et al. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. Br J Haematol. 1998 Jun;101(4):766-9.